The membership of the North American Skull Base Society (NASBS) is a tremendous resource for the training of fellows, who are the future of the development of our specialty. The society has developed a registry of skull base fellowships that are offered by the society membership.
The society recognizes that we are a diverse and multidisciplinary group comprised of several different specialties, all of whom have significant interest and focus in the management of skull base neoplasia. Likewise, the nature and character of the various fellowships will represent and reflect their differences. In addition, we recognize that there will be variation between individual fellowship experiences resulting from the differences in the preceptor’s approaches and practices.
To post a Fellowship, please go to the Fellowship Registry Entry Form. You must be a member of NASBS to add a Fellowship to the Registry.
To edit an entry, please log in under the Member credentials used to add the entry to the registry and make edits to the listing.
To apply for Fellowship training, please contact the program directly.
If you need assistance or have questions, please contact the NASBS office at [email protected].
| Title of Fellowship | Rhinology and Skull Base Surgery Fellowship |
|---|---|
| Contact Name for Applications | Toni Holthaus |
| Fellowship Type |
|
| Location | Kansas City, KS |
| Date Fellowship Established | 07/01/2016 |
| Fellowship Director | Donald David Beahm, MD |
| Participating Faculty | Alexander Chiu, MD |
Fellowship Information | |
| Duration | 1 year |
| Required Prior Training Program |
|
| Required Prior Training Program Other | None |
| Accept Foreign Medical Graduates (outside US & Canada) | No |
| Residency Training in US/Canada Required | Yes |
| USMLE |
|
| Percentage of Fellow Workload that is Skull Base | 80% |
| Number of Fellows Accepted Per Year | 1 |
| Salaried Position | Yes- contact Program Director for more information |
| Night and Weekend Call | Yes |
| Estimated Nights Per Month | 3 weeks per year |
| Clinical Work | |
| Open Cranial Base | |
| Endonasal Cranial Base | |
| Temporal Bone | |
| Craniofacial Anomalies/ Reconstructive | |
| Trauma | |
| Craniocervical | |
| Reconstruction | |
| Stereotactic Radiosurgery | |
| Cerebral Vascular Surgery | |
| Anatomical Dissection Laboratory | Daniel Carlton, MD |
| Laboratory Research Opportunities | Laboratory research is available within the Department of Otolaryngology Head and Neck Surgery through our faculty Sufi Thomas, PhD. Dr. Thomas’s main focus has been to understand the biological mechanisms involved in head and neck squamous cell carcinoma (HNSCC) progression and to develop effective therapeutic interventions. Currently Dr. Thomas’s lab is focused on the study of the interaction of fibroblasts and cancer cells in squamous cell carcinoma of the head and neck. Emerging evidence demonstrates molecular cross talk between HNSCC and fibroblasts that increase tumor growth, invasion into surrounding tissue and metastasis. Dr. Thomas is in the process of identifying signaling molecules involved in the cross-talk between HNSCC and fibroblasts in order to block tumor growth and metastasis. The findings from these studies has tremendous potential in target identification and therapeutic development. In recent years, Dr. Thomas’s lab has worked with a number of otolaryngology residents to create a Juvenile Nasopharyngeal Angiofibroma cell line. She and her collaborators have tested out a number of therapies to suspend the growth and effect the fibroblasts involved. This work has resulted in a number of podium presentations and publications for the residents involved. Dr. Thomas has also designed a GPNA antisense oligomer complementary to EGFR mRNA (EGFRAS GPNA). EGFRAS GPNA treatment results in tumor growth inhibition on systemic delivery in animal models. Identification of other targets with therapeutic potential that lack specific inhibitors is currently underway. This method of systemically delivered antisense oligonucleotides holds immense potential for personalized cancer therapy. |
| Application Deadline | 01/22/2019 |
| Decision Deadline | 05/20/2019 |
| Fellowship Institution Website | kumc.edu |
| Previous Fellows | Vidur Bhalla, MD |
| Additional Features of the Fellowship | Under the direction of the department clinical research director, Kevin Sykes, PhD and department Chair and rhinology fellowship co-director, Alexander Chiu, MD, there is a robust research program in place. A weekly 2-hour research meeting is attended by the fellow, 5-6 department faculty including Chiu, Sykes, Villwock and Bhalla, our department IRB coordinator, grants program manager and 2 residents on research rotation. Clinical trial design and accountability of ongoing projects is core to these meetings and the expectation is for the fellow to complete, at minimum, at least two independent projects resulting in presentation and publication. The fellow will also learn how to review rhinology articles alongside Dr. Alexander Chiu, past editor-in-chief of the American Journal of Rhinology and Allergy. Additionally, as Drs. Beahm and Villwock currently review for three otolaryngology journals, the fellow will have access to the review process with them as well. Dr. Chiu is also the editor-in-chief of ENT today and the fellow will be exposed to the editorial and managing process of that journal. It is expected that all fellows will be involved in clinical research projects and participate in the presentation/publication of the results. |
| Committee on Advanced Subspecialty Training (CAST) Accredited | Yes |
| Fellowship Approved By |
|
| How to apply | SF Match |